Related Experiment Video
Updated: Jun 7, 2025

10:08
An Economical and Versatile High-Throughput Protein Purification System Using a Multi-Column Plate Adapter
Published on: May 21, 2021
4.2K
A high-performance protein preparation approach in a single column-free step
Yuan Huang1, Yuanyuan Zhang1, Xiaofeng Yang1
1School of Biology and Biological Engineering, South China University of Technology, Guangzhou, Guangdong 510006, China.
Trends in Biotechnology
|November 13, 2024
Summary
A novel column-free protein purification method, the cleavable self-aggregating tag 2.0 (cSAT2.0) scheme, significantly improves protein production efficiency and purity in Escherichia coli. This cost-effective platform is scalable from microplates to fermenters.
Area of Science:
- Biotechnology
- Protein Biochemistry
- Molecular Biology
Background:
- Protein purification is a critical yet challenging and expensive step in biotechnology.
- Existing methods often involve costly columns and complex procedures.
- There is a need for more efficient and economical protein production strategies.
Purpose of the Study:
- To introduce and validate a new column-free protein purification method, the cleavable self-aggregating tag 2.0 (cSAT2.0) scheme.
- To demonstrate the efficiency, purity, and scalability of the cSAT2.0 scheme for protein production.
- To establish cSAT2.0 as a robust and economical platform for recombinant protein expression.
Main Methods:
- Development and application of the cleavable self-aggregating tag 2.0 (cSAT2.0) scheme for protein purification.
- Expression of six proteins (one peptide, five proteins) in Escherichia coli using shake-flask cultures in lysogeny broth (LB) medium.
- High-throughput protein preparation using microplates.
- Scale-up fermentation of caplacizumab in a 5-l fermenter.
Main Results:
- The cSAT2.0 scheme yielded high quantities of proteins, ranging from 24 mg/l to 89 mg/l, with exceptional purity exceeding 98%.
- Successful high-throughput protein preparation was achieved on microplates.
- Scale-up fermentation of caplacizumab resulted in 1.4 g/l of highly purified protein.
- The method demonstrated broad applicability across different proteins and scales.
Conclusions:
- The cSAT2.0 scheme offers a streamlined, column-free approach for efficient and high-purity protein production.
- This method is cost-effective and scalable, suitable for various applications from laboratory research to industrial production.
- The cSAT2.0 scheme represents a significant advancement in biotechnology for recombinant protein manufacturing.

